Investing
407 articlesReaders can find walk-throughs, comparisons, examples and updates tied to compound returns, brokerage accounts and fund expense ratios, with attention to stock ownership, bond yields and diversification strategy when those details affect costs, rights, exposure or timing.
Nasdaq Composite faces volatile path as tech valuations soar
If the Nasdaq Composite repeats its historical 11 percent annual return, the index could triple by 2036-but past periods of stagnation and current tech valuations highlight the risk of sharp reversals
Nvidia and Broadcom face diverging fortunes after GPT-6 Astra launch
Nvidia shares slipped while Broadcom surged after OpenAI's GPT-6 Astra debut. Jim Cramer's latest call spotlights the shifting power struggle among AI chipmakers and what it means for investors betting on the next wave of AI infrastructure
Bank of America warns stocks face $163B forced selling risk
A rare alignment of Wall Street risk models points to a massive $163 billion forced-selling threat for stocks as systematic funds run out of buying power and traditional demand pillars weaken
JPMorgan slashes silver outlook as Fed rate risk hits investors
JPMorgan has cut its 2027 silver price forecast by 26 percent, signaling that the metal's rally may have already run its course and leaving recent buyers facing steep potential losses if rates stay high
Rising Rate Hike Odds Threaten AI Stock Rally
With the probability of a Federal Reserve rate hike in September climbing above 60 percent, investors must weigh the risk that higher borrowing costs could halt the AI-driven stock surge and reshape market expectations for the rest of 2026.
Federal Reserve faces credibility test as rate hike looms
With inflation still above target and political pressure mounting, the Federal Reserve's September 16 rate decision could trigger short-term volatility and force investors to reconsider how they protect their portfolios against rising prices
Berkshire Hathaway cash hoard shrinks as Abel bets big on stocks
Berkshire Hathaway's new CEO Greg Abel has slashed the company's record cash pile by $32 billion in just one quarter, reversing Warren Buffett's cautious approach and triggering debate over whether this bold deployment will pay off for investors
AI Stocks Drive Relentless Market Rally as Bull Run Defies Skeptics
The S&P 500 has soared more than 100 percent since late 2022, with AI stocks leading the charge. As valuations stretch and more sectors join the rally, investors face a critical question about how long the bull market can last.
Kevin O'Leary's Five Investing Rules That Could Save Your Portfolio
Kevin O'Leary reveals the five rules he uses to avoid catastrophic losses and keep his money working. His approach rejects hot tips and market timing in favor of strict risk controls and income discipline
Why I Am Buying Internatiaonal Stocks With Vanguard VXUS
With US stock valuations stretched and AI-driven gains dominating headlines, some investors are turning to the Vanguard Total International Stock ETF for broader exposure and lower costs. Here is what sets VXUS apart
Berkshire Hathaway signals new AI investment strategy under Greg Abel
Berkshire Hathaway is weighing a more assertive approach to AI investments as CEO Greg Abel considers adding major tech stocks like Alphabet, Microsoft, and Nvidia to drive growth and attract new investors
Warren Buffett's Value Playbook Faces the Generative AI Frenzy
As generative AI stocks push the S&P 500 to new highs, Warren Buffett's focus on durable business advantages offers a counterpoint to speculative bets and bubble risk in today's market
Investors who keep buying during market dips build long term wealth
September has a reputation for stock market losses but investors who keep buying through downturns have historically outperformed those who try to time the market or sit on the sidelines
Smart Money Backs European AI Lab as Biotech Bets Stumble
Samsung's $3.5 billion investment in French AI startup Mistral signals global demand for AI infrastructure even as biotech stocks like Ionis and Novartis face setbacks after disappointing drug trial results
Financial advisor fees can quietly drain your returns
Many investors overlook the true cost of financial advice and the conflicts that come with it. Understanding how your advisor is paid can mean the difference between growing your wealth and subsidizing someone else's bottom line
Kevin O'Leary's 15 Percent Savings Rule Faces a Harsh Paycheck Reality
Kevin O'Leary's 15 percent savings formula promises millions, but the median 401(k) balance is just $44,115 as rising rates and real incomes reveal the gap between theory and reality.
Michael Burry bets on Birkenstock as Wall Street doubts linger
Michael Burry has taken a 5.2% stake in Birkenstock after shares fell 17 percent this year despite rising sales and a bullish outlook. His move tests whether durability and brand loyalty can outlast market skepticism.
Retirees Face a Yield or Growth Dilemma in Volatile Markets
Many retirees hesitate to spend their savings, fearing they will outlive their money. Choosing between high-yield income and long-term growth investments can create risks if not balanced with cash reserves and a clear withdrawal plan.
Nike dividend yield spikes as stock hits twelve year low
Nike's dividend yield has soared to 4.3 percent after a steep share price drop. Here's how much you'd need to invest to collect one thousand dollars in annual dividends-and what risks come with that payout
Biotech bankruptcy wipes out investors before FDA decision arrives
BioXcel filed for bankruptcy just weeks before a pivotal FDA ruling on its only approved drug. The company's lenders and buyers will collect any upside while shareholders are left with nothing
Bear Markets Offer Rare Openings for Patient Investors
Bear markets have historically delivered steep declines but also rare chances to buy strong companies at lower prices. Investors who prepare for volatility and keep buying during downturns may see better long-term results.
Silver Faces New Pressure as Investors Seek Safe Havens
Silver prices have dropped sharply from their January peak but rising political and economic uncertainty could push demand higher as investors look for alternatives to stocks and traditional safe havens
How Much Realty Income Stock Delivers One Hundred Dollars Monthly
Realty Income pays dividends every month not just quarterly. Here is the exact investment required to generate one hundred dollars in monthly income and what risks and rewards investors face with this REIT.
Stock valuations reach dot-com era highs as investors weigh risk
The S&P 500's CAPE ratio has soared above 40 for only the second time in history, raising the risk of a future correction and forcing investors to reconsider how much risk they are willing to take in their portfolios
Health Care ETF Shows Strength as Rate Hike Pressure Builds
With the Federal Reserve signaling a possible rate hike to combat persistent inflation, the State Street Health Care Select Sector SPDR ETF stands out for its resilience and dividend profile during volatile market cycles
Oil Price Spike Drives Inflation Pressure Ahead of Fed Decision
With oil above $90 a barrel and inflation stuck well above target, the August CPI report could force the Fed's hand on rates-putting stocks and household budgets at risk if energy costs keep climbing
S&P 500 Index Funds Reshape Long-Term Investing in the US
A $10,000 investment in an S&P 500 index fund a decade ago could now be worth over $38,000. But recent returns far outpace the long-term average, and most managed funds still lag behind this broad market benchmark.
Tesla and SpaceX losses hit ARK Innovation ETF after Cybercab event
Tesla's nearly 6 percent drop after its Cybercab launch and a federal safety audit triggered a decline in ARK Innovation ETF which has 16 percent of its assets tied to Tesla and SpaceX
ETF Investors Flee Tech and Financials as $11B Rotates to Bonds, Health Care
August saw $11 billion pulled from tech and financial ETFs, even as total ETF inflows hit a record $180 billion. Investors shifted capital to bonds and health care, signaling a decisive move toward defensive and income-generating assets amid valuation concerns.
Nuvation Bio stock rockets after FDA fast track, but Cramer urges caution
Nuvation Bio shares have surged following a pivotal FDA fast track for its brain cancer drug, but Jim Cramer warns that the company's valuation still hinges on unproven pipeline therapies and volatile clinical outcomes.
Buffett's Crisis Playbook: Why Panic Selling Costs Investors Most
Warren Buffett's disciplined approach urges investors to resist panic selling during 2026's market swings, as Berkshire Hathaway shifts billions into stocks and data shows long-term holders consistently outperform those who react to headlines.
Buffett Expands New York Times Stake as Digital Profits Outpace Rivals
Berkshire Hathaway has quietly expanded its position in The New York Times, signaling rare conviction in legacy media as digital subscriptions and advertising revenue reach record highs and outpace industry peers.
Nvidia's $2 Billion Nscale Stake Redraws AI Cloud Power Map
Nvidia is injecting $2 billion into Nscale's pre-IPO round as the AI cloud startup's contract backlog surges past $100 billion. The deal tightens Nvidia's grip on AI infrastructure and tests the durability of vendor-financed growth.
Tariff Announcements Trigger Wild Swings in US Stock Market
Frequent tariff policy changes from the White House have driven sharp swings in major US stocks, with single-day losses wiping out trillions and sudden reversals leaving investors scrambling to adapt to unpredictable trade moves
Long Term Investing Wins When Markets Zigzag
Trying to outsmart the market often backfires while investors who stick with a disciplined buy and hold approach have historically come out ahead even through sharp downturns and wild swings
Buffett Strategy Faces Test as Market Valuations Hit Extreme Levels
With the S&P 500 up over 250 percent in the past decade and key valuation metrics flashing red, investors face a dilemma as market risks mount and Warren Buffett's approach to cash and steady buying is put to the test
SCHD closes in on VIG as dividend ETF rivalry reshapes portfolios
SCHD has surged nearly 30 percent this year while VIG lags far behind. With yields and sector bets diverging sharply, the stakes for retirement and income investors are rising fast
Howmet Aerospace Plunge Tests Nerves as SpaceX Sparks Turbine Shock
Elon Musk's SpaceX move to cast its own turbine blades erased billions from Howmet Aerospace's market cap in hours. Analysts and Jim Cramer now see a rare buying window, but warn that Howmet's lofty valuation leaves investors exposed to sharp reversals.
Why I Keep Buying the Vanguard Morningstar Total Stock Market ETF
Vanguard Morningstar Total Stock Market ETF offers exposure to over 3,500 U.S. stocks with a 0.03% expense ratio and has outperformed the S&P 500's long-term average over the past decade, but investors should weigh diversification against market risk
AI-fueled tech giants drive S&P 500 risk to record highs
S&P 500 index funds now expose investors to unprecedented concentration in AI and mega-cap tech stocks, as market cap weighting and rising Treasury yields amplify portfolio risks and challenge assumptions about diversification.
Page 1 by 11